Study Summary
This trial study is trying to find ways to make the VERDI model more accessible to a more diverse group of people who are at risk for hereditary cancers.
Eligible Conditions
- Prostate Cancer
- Genetic Testing
- Melanoma
- Ovarian Cancer
- Breast Cancer
- Pancreatic Cancer
- Kidney Cancer
- Sarcoma
- Colorectal Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 3 Weeks
3 Weeks
Video Education Acceptability (Qualitative Interview Study)
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
QUALITATIVE ASSESSMENT
1 of 3
RCT-VERDI
1 of 3
RCT-Genetic Counseling
1 of 3
Experimental Treatment
1020 Total Participants · 3 Treatment Groups
Primary Treatment: Genetic Counseling · No Placebo Group · N/A
QUALITATIVE ASSESSMENT
Behavioral
Experimental Group · 1 Intervention: Video Education · Intervention Types: BehavioralRCT-VERDI
Behavioral
Experimental Group · 1 Intervention: Video Education · Intervention Types: BehavioralRCT-Genetic Counseling
Behavioral
Experimental Group · 1 Intervention: Genetic Counseling · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Genetic Counseling
2008
Completed Phase 3
~4940
Video Education
2017
N/A
~200
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 weeks
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,071 Previous Clinical Trials
41,127,835 Total Patients Enrolled
536 Trials studying Prostate Cancer
501,376 Patients Enrolled for Prostate Cancer
Dana-Farber Cancer InstituteLead Sponsor
1,016 Previous Clinical Trials
392,796 Total Patients Enrolled
67 Trials studying Prostate Cancer
15,091 Patients Enrolled for Prostate Cancer
National Human Genome Research Institute (NHGRI)NIH
251 Previous Clinical Trials
277,803 Total Patients Enrolled
4 Trials studying Prostate Cancer
13,240 Patients Enrolled for Prostate Cancer
Huma Q. Rana, MD., MPHPrincipal InvestigatorDana-Farber Cancer Institute
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are able to understand the nature and purpose of the study and are willing to sign a written informed consent document.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments